none20We faced the basic question on chronological versus biological age at tissue level in the context of organ transplant. By means of a comprehensive approach we analysed nuclear and mitochondrial DNA, mRNAs, microRNAs, proteins, including proteasome and immunoproteasome, obtained from liver biopsies of donors with different age (13-90 years) to identify biomarkers of biological age. Telomere length and specific miRNAs appear to be important biomarkers of liver aging. This research looks for the improvement of the graft management getting insights into donor- recipient age- mismatch effects.mixedM. Capri; F. Olivieri; D. Remondini; C. Lanzarini; R. Lazzarini; E. Bellavista; M. Martucci; A. Santoro; F. Biondi; E. Tenedini; E. Tagliafico; ...
open11noThis work has been partially supported by the European Union (EU)’s H2020 Project “Propag-ag...
It has been reported that donor age affects patient outcomes after liver transplantation, and that t...
It has been reported that donor age affects patient outcomes after liver transplantation, and that t...
We faced the basic question on chronological versus biological age at tissue level in the context of...
We faced the basic question on chronological versus biological age at tissue level in the context of...
To understand why livers from aged donors are successfully used for transplants, we looked for marke...
AbstractBackgroundLiver transplantation is used to treat patients with irreversible liver failure fr...
open11noThis work has been partially supported by the European Union (EU)’s H2020 Project “Propag-ag...
It has been reported that donor age affects patient outcomes after liver transplantation, and that t...
It has been reported that donor age affects patient outcomes after liver transplantation, and that t...
We faced the basic question on chronological versus biological age at tissue level in the context of...
We faced the basic question on chronological versus biological age at tissue level in the context of...
To understand why livers from aged donors are successfully used for transplants, we looked for marke...
AbstractBackgroundLiver transplantation is used to treat patients with irreversible liver failure fr...
open11noThis work has been partially supported by the European Union (EU)’s H2020 Project “Propag-ag...
It has been reported that donor age affects patient outcomes after liver transplantation, and that t...
It has been reported that donor age affects patient outcomes after liver transplantation, and that t...